medigraphic.com
ISSN 1810-2352 (Print)

2012, Number 4

<< Back Next >>

Rev Cub Med Int Emerg 2012; 11 (4)

Hyponatraemia in neurointensive care

Doberenz DT

Language: Spanish
References: 35
Page: 2619-2630
PDF size: 107.02 Kb.


ABSTRACT

Hyponatremia is a frequent complication of brain injury and disease. It requires assessment and management of all contributing factors. If acute and severe, initial treatment with hypertonic saline may be necessary, irrespective of the exact underlying cause. The traditional distinction of cerebral salt wasting (CSW) and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is not always helpful for clinical management.


REFERENCES

  1. Sherlock ME, O'Sullivan et al. (2006). The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 64(3): 250- 4.

  2. Kao LZ. Al-Lawati, et al. (2009). Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary 12(4): 347-51.

  3. Peters JP, Welt LG et al. (1950). A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63: 57-64.

  4. Cort JH. (1954). Cerebral salt wasting. Lancet 266(6815): 752-4.

  5. Carter NW, FC Rector Jr et al. (1961). Hyponatremia in cerebral disease resulting from the inappropriate secretion of antidiuretic hormone. N Engl J Med 264: 67-72.

  6. Sterns RH and Silver M. (2008). Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 19(2): 194-6.

  7. Brimioulle S, Orellana-Jimenez C, et al. (2008). Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antidiuretic hormone secretion. Intensive Care Med 34(1): 125-31.

  8. Nelson PB, Seif SM, et al. (1981). Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg 55(6): 938-41.

  9. Singh S, Bohn D, et al. (2002). Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 30(11): 2575-9.

  10. 10.Berendes E, Walter M, et al. (1997). Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349(9047): 245-9.

  11. Taplin CE, Cowell CT, et al. (2006). Fludrocortisone therapy in cerebral salt wasting. Pediatrics 118(6): e1904-8.

  12. Audibert G, Steinmann G, et al. (2009). Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg 108(6): 1922-8.

  13. Moritz ML. and Ayus JC. (2003). The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant 18(12): 2486- 91.

  14. Verbalis JG, Goldsmith SR, et al. (2007). Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 120(11 Suppl 1): S1-21.

  15. 15.Hew-Butler Ayus T, JC, et al. (2008). Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med 18(2): 111-21.

  16. Shippy CR, Appel PL, et al. (1984). Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med 12(2): 107-12.

  17. Schneider HJ, Kreitschmann-Andermahr I, et al. (2007). Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298(12): 1429-38.

  18. 18.Zhang Y, Mircheff AK, et al. (1996). Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis. Am J Physiol 270(6 Pt 2): F1004-14.

  19. 19.Cohan P, Wang C, et al. (2005). Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med 33(10): 2358-66.

  20. 20.Bernard F, Outtrim J, et al. (2006). Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications. Br J Anaesth 96(1): 72-6.

  21. Powner DJ, Boccalandro C, et al. (2006). Endocrine failure after traumatic brain injury in adults. Neurocrit Care 5(1): 61-70.

  22. 22.Dusick JR, Wang C, et al. (2008). Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury. Pituitary.

  23. Powner DJ and Boccalandro C. (2008). Adrenal insufficiency following traumatic brain injury in adults. Curr Opin Crit Care 14(2): 163-6.

  24. 24.Cohen J, Ward G, et al. (2006). Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med 32(11): 1901-5.

  25. Hamrahian AH, Oseni TS, et al. (2004). Measurements of serum free cortisol in critically ill patients. N Engl J Med 350(16): 1629-38.

  26. Fiad TM, Cunningham SK, et al. (1997). Effects of nifedipine treatment on the reninangiotensin- aldosterone axis. J Clin Endocrinol Metab 82(2): 457-60.

  27. 27.Kosaka H, Hirayama K, et al. (2010). The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family. Eur J Pharmacol 635(1-3): 49-55.

  28. Ellison DH and Berl T. (2007). Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356(20): 2064-72.

  29. Hannon MJ and Thompson CJ. (2010). The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol 162 Suppl 1: S5- 12. 30.Moro N, Katayama Y, et al. (2003). Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke 34(12): 2807-11.

  30. 31.Katayama Y, Haraoka J, et al. (2007). A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 38(8): 2373-5.

  31. Hasan D, Lindsay KW, et al. (1989). Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 20(9): 1156-1161.

  32. 33.Berl T. (2000). Mannitol: a therapeutic alternative in the treatment of acute hyponatremia? Crit Care Med 28(6): 2152-3.

  33. Schrier RW, Gross P, et al. (2006). Tolvaptan, a selective oral vasopressin V2- receptor antagonist, for hyponatremia. N Engl J Med 355(20): 2099-112.

  34. Marik PE, Pastores SM, et al. (2008). Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36(6): 1937-49.

  35. 36.Bederson JB, Connolly ES Jr., et al. (2009). Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40(3): 994-1025.




2020     |     www.medigraphic.com